단일염기다형성(SNP) 지노타이핑 : 세계 시장 점유율과 순위, 총판매량 및 수요 예측(2025-2031년)
Single Nucleotide Polymorphism (SNP) Genotyping - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
상품코드:1872176
리서치사:QYResearch
발행일:2025년 10월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 단일염기다형성(SNP) 지노타이핑 시장 규모는 2024년에 247억 1,000만 달러로 추정되며, 2025-2031년의 예측 기간에 CAGR 21.1%로 성장하며, 2031년까지 927억 5,000만 달러로 확대할 것으로 예측되고 있습니다.
단일염기다형성(SNP) 유전형질분석은 동일 종내 개체 간에 관찰되는 단일염기다형성(SNP)의 유전적 변이를 측정하는 방법입니다. 이는 보다 광범위한 유전적 변이를 측정하는 유전형질의 한 형태입니다. SNP 유전자형 분석은 가장 많이 존재하는 유전자 마커일 뿐만 아니라 가장 유망한 마커이기도 합니다. 분자 마커 개발에서 가장 큰 잠재력을 가지고 있으며, 대규모 및 첨단 자동화를 실현할 수 있으므로 방대한 수의 검출 및 분석에 적합합니다. 생물학, 농업, 의학, 생물 진화 등의 분야에서 널리 활용되고 있습니다.
세계 SNP 유전체 분석의 주요 기업으로는 Illumina, Affymetrix, Applied Biosystems, Agilent Technologies, Beckman Coulter 등을 들 수 있습니다. 상위 5개사의 점유율은 약 65%를 차지하고 있습니다. 북미가 가장 큰 시장으로 약 40%의 점유율을 차지하고 있으며, 유럽과 일본이 약 35%를 차지하고 있습니다. 제품별 부문에는 전위(Transversion)와 전이(Transition)가 포함됩니다. 용도별로는 진단용이 가장 큰 비중을 차지하고 있으며, 동물, 식물, 조사 등이 그 뒤를 잇고 있습니다.
이 보고서는 단일염기다형성(SNP) 유전자형 분석 세계 시장에 대해 총매출액, 주요 기업의 시장 점유율 및 순위를 중심으로 지역별, 국가별, 유형별, 용도별 분석을 종합적으로 제시하는 것을 목적으로 합니다.
SNP 유전자형 분석 시장 규모, 추정치 및 예측은 2024년을 기준 연도로 하여 2020-2031년의 과거 데이터와 예측 데이터를 기반으로 한 판매 매출로 제공됩니다. 정량적, 정성적 분석을 통해 독자들이 비즈니스/성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 포지셔닝 분석, SNP 유전형 분석에 대한 정보에 기반한 비즈니스 의사결정을 내릴 수 있도록 도와드립니다.
시장 세분화
기업별
Illumina
Affymetrix
Applied Biosystems
Agilent Technologies
Beckman Coulter
Roche
Qiagen
Luminex Corporation
Enzo Life Sciences
Bio-rad
Sequenom
Ocimum Biosolutions
GE Healthcare
GenScript
Douglas Scientific
BGI
Beijing Sunbiotech
HuaGene Biotech
Generay Biotech
Benegene
Shanghai Biochip
GENESKY
HD Biosciences
유형별 부문
트랜지션
트랜스버전
용도별 부문
진단
동물
식물
연구
기타
지역별
북미
미국
캐나다
아시아태평양
중국
일본
한국
동남아시아
인도
호주
기타 아시아태평양
유럽
독일
프랑스
영국
이탈리아
네덜란드
북유럽 국가
기타 유럽
라틴아메리카
멕시코
브라질
기타 라틴아메리카
중동 및 아프리카
튀르키예
사우디아라비아
아랍에미리트
기타 중동 및 아프리카
KSA
영문 목차
영문목차
The global market for Single Nucleotide Polymorphism (SNP) Genotyping was estimated to be worth US$ 24710 million in 2024 and is forecast to a readjusted size of US$ 92750 million by 2031 with a CAGR of 21.1% during the forecast period 2025-2031.
Single Nucleotide Polymorphism (SNP) Genotyping is the measurement of genetic variations of single nucleotide polymorphisms (SNPs) between members of a species. It is a form of genotyping, which is the measurement of more general genetic variation. SNP genotyping is not only the genetic markers present in most, but also the most promising markers. SNP genotyping as the most potential for development of molecular markers, it cans achieve large-scale highly automated, thus it is more suited to a huge number of detection and analysis, has been widely used in biology, agriculture, medicine, biological evolution and other fields.
Global Single Nucleotide Polymorphism (SNP) Genotyping key players include Illumina, Affymetrix, Applied Biosystems, Agilent Technologies, Beckman Coulter, etc. Global top five players hold a share about 65%. North America is the largest market, with a share about 40%, followed by Europe and Japan, having a total share about 35 percent. In terms of product, the segment includes Transversion, Transition. And in terms of application, the largest application is Diagnostics, followed by Animal, Plant, Research, etc.
This report aims to provide a comprehensive presentation of the global market for Single Nucleotide Polymorphism (SNP) Genotyping, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Single Nucleotide Polymorphism (SNP) Genotyping by region & country, by Type, and by Application.
The Single Nucleotide Polymorphism (SNP) Genotyping market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single Nucleotide Polymorphism (SNP) Genotyping.
Market Segmentation
By Company
Illumina
Affymetrix
Applied Biosystems
Agilent Technologies
Beckman Coulter
Roche
Qiagen
Luminex Corporation
Enzo Life Sciences
Bio-rad
Sequenom
Ocimum Biosolutions
GE Healthcare
GenScript
Douglas Scientific
BGI
Beijing Sunbiotech
HuaGene Biotech
Generay Biotech
Benegene
Shanghai Biochip
GENESKY
HD Biosciences
Segment by Type
Transversion
Transition
Segment by Application
Diagnostics
Animal
Plant
Research
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Single Nucleotide Polymorphism (SNP) Genotyping company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Single Nucleotide Polymorphism (SNP) Genotyping in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Single Nucleotide Polymorphism (SNP) Genotyping in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Single Nucleotide Polymorphism (SNP) Genotyping Product Introduction
1.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast (2020-2031)
1.3 Single Nucleotide Polymorphism (SNP) Genotyping Market Trends & Drivers
1.3.1 Single Nucleotide Polymorphism (SNP) Genotyping Industry Trends
1.3.2 Single Nucleotide Polymorphism (SNP) Genotyping Market Drivers & Opportunity
1.3.3 Single Nucleotide Polymorphism (SNP) Genotyping Market Challenges
1.3.4 Single Nucleotide Polymorphism (SNP) Genotyping Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Players Revenue Ranking (2024)
2.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Company (2020-2025)
2.3 Key Companies Single Nucleotide Polymorphism (SNP) Genotyping Manufacturing Base Distribution and Headquarters
2.4 Key Companies Single Nucleotide Polymorphism (SNP) Genotyping Product Offered
2.5 Key Companies Time to Begin Mass Production of Single Nucleotide Polymorphism (SNP) Genotyping
2.6 Single Nucleotide Polymorphism (SNP) Genotyping Market Competitive Analysis
2.6.1 Single Nucleotide Polymorphism (SNP) Genotyping Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Single Nucleotide Polymorphism (SNP) Genotyping Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Single Nucleotide Polymorphism (SNP) Genotyping as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Transversion
3.1.2 Transition
3.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Sales Value by Type
3.2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Sales Value, by Type (2020-2031)
3.2.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Diagnostics
4.1.2 Animal
4.1.3 Plant
4.1.4 Research
4.1.5 Others
4.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Sales Value by Application
4.2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Sales Value, by Application (2020-2031)
4.2.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Sales Value by Region
5.1.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Sales Value by Region (2020-2025)
5.1.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Sales Value by Region (2026-2031)
5.1.4 Global Single Nucleotide Polymorphism (SNP) Genotyping Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Sales Value, 2020-2031
5.2.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Sales Value, 2020-2031
5.3.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Single Nucleotide Polymorphism (SNP) Genotyping Sales Value, 2020-2031
5.4.2 Asia Pacific Single Nucleotide Polymorphism (SNP) Genotyping Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Single Nucleotide Polymorphism (SNP) Genotyping Sales Value, 2020-2031
5.5.2 South America Single Nucleotide Polymorphism (SNP) Genotyping Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Sales Value, 2020-2031
5.6.2 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Single Nucleotide Polymorphism (SNP) Genotyping Sales Value Growth Trends, 2020 VS 2024 VS 2031
